Revascularization of dysfunctioning myocardium: Differential prognostic effects of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients with three-vessel disease and mostly viable myocardium

Interactive Cardiovascular and Thoracic Surgery

Volumn 2, Issue 3, 2003, Pages 301-306

  Gimelli, Alessia ^a   Glauber, Mattia ^a   Giorgetti, Assuero ^a   Sambuceti, Gianmario ^a   L'Abbate, Antonio ^a   Marzullo, Paolo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Multivessel disease; Myocardial viability; Percutaneous transluminal coronary angioplasty; Surgical revascularization

Indexed keywords

THALLIUM;

ADULT; AGED; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MYOCARDIAL DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE;

EID: 0041384275     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(03)00064-1     Document Type: Review

References (15)

1. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial. JAMA. 277:1997;715-721.
2. Rodriguez A., Bernardi V., Navia J., Baldi J., Grinfeld L., Martinez J., Vogel D., Grinfeld R., Delacasa A., Garrido M., Oliveri R., Mele E., Palacios I., O'Neill W. Argentine randomized study: coronary angioplasty stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol. 37:2001;51-58.
3. Jones R.H., Kesler K., Phillips H.R., Mark D.B., Smith P.K., Nelson C.L., Newman M.F., Reves J.G., Anderson R.W., Califf R.M. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 111:1996;1013-1025.
4. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
5. Hannan E.L., Racz M.J., McCallister B.D., Ryan T.J., Arani D.T., Isom O.W., Jones R.H. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 33:1999;63-72.
6. Berger P.B., Velianou J.L., Vlachos H.A., Feit F., Jacobs A.K., Faxon D.P., Attubato M., Keller N., Stadius M.L., Weiner B.H., Williams D.O., Detre K.M. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. J Am Coll Cardiol. 38:2001;1440-1449.
7. Dreyfus G.D., Duboc D., Blasco A., Vigoni F., Dubois C., Brodaty D., de Lentdecker P., Bachet J., Goudot B., Guilmet D. Myocardial viability assessment in ischaemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 57:1994;1402-1408.
8. Pagano D., Townend J.N., Littler W.A., Horton R., Camici P.G., Bonser R.S. Coronary artery bypass surgery as treatment for ischaemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg. 115:1998;791-799.
9. Schiller N.B., Shah P.M., Crawford, De Maria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Reccomendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo. 2:1989;358-367.
10. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
11. Goy J.J., Eeckout E., Moret C., Burnand B., Vogt P., Stauffer J.C., Hurni M., Stumpe F., Ruchat P., von Sefesser L., Urban P., Kappenberger L. Five-year outcome in patients with isolated proximal anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. Circulation. 99:1999;3255-3259.
12. Greenbaum A.B., Califf R.M., Jones R.H., Gardner L.H., Phillips H.R., Sketch M.H., Stack R.S., Puma J.A. Comparison of medicine alone, coronary angioplasty and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. J Am Coll Cardiol. 86:2000;1322-1326.
13. Kurbaan A.S., Bowker T.J., Ilsley C.D., Rickards A.F. Impact of postangioplasty restenosis on comparison of outcome between angioplasty and bypass grafting. Coronary Angioplasty versus Bypass Revascularization Investigation (CABRI) Investigators. Am J Cardiol. 82:1998;272-276.
14. Moussa I., Reimers B., Moses J., Di Mario C., Di Francesco L., Ferraro M., Colombo A. Long term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. Circulation. 96:1997;3873-3890.
15. Del Rizzo D.F., Boyd W.D., Novick R.J., McKenzie F.N., Desai N.D., Menkis A.H. Safety and cost effectiveness of MIDCABG in high risk CABG patiets. Ann Thorac Surg. 66:1998;1002-1007.